<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="methods-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Oncol.</journal-id>
<journal-title>Frontiers in Oncology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Oncol.</abbrev-journal-title>
<issn pub-type="epub">2234-943X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fonc.2024.1407919</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Oncology</subject>
<subj-group>
<subject>Study Protocol</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Implementing fencing as adapted physical activity in non-metastatic breast cancer patients: design and early rehabilitation strategy of the FENICE study protocol</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Berretta</surname>
<given-names>Massimiliano</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/310688"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Garozzo</surname>
<given-names>Daniele</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2424817"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Foti</surname>
<given-names>Calogero</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1418154"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Roselli</surname>
<given-names>Mario</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1590976"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Materazzo</surname>
<given-names>Marco</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/981077"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vita</surname>
<given-names>Giulia</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2427824"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Iellamo</surname>
<given-names>Ferdinando</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Scordari</surname>
<given-names>Marco</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Di Mauro</surname>
<given-names>Giordana</given-names>
</name>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Spatari</surname>
<given-names>Giovanna</given-names>
</name>
<xref ref-type="aff" rid="aff7">
<sup>7</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ottaiano</surname>
<given-names>Alessandro</given-names>
</name>
<xref ref-type="aff" rid="aff8">
<sup>8</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2008781"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Noce</surname>
<given-names>Annalisa</given-names>
</name>
<xref ref-type="aff" rid="aff9">
<sup>9</sup>
</xref>
<xref ref-type="aff" rid="aff10">
<sup>10</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/967122"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pellicciaro</surname>
<given-names>Marco</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bignucolo</surname>
<given-names>Alessia</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2698357"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vanni</surname>
<given-names>Gianluca</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<xref ref-type="author-notes" rid="fn004">
<sup>&#x2021;</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Buonomo</surname>
<given-names>Oreste Claudio</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<xref ref-type="aff" rid="aff11">
<sup>11</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<xref ref-type="author-notes" rid="fn004">
<sup>&#x2021;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/981088"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Clinical and Experimental Medicine, University of Messina</institution>, <addr-line>Messina</addr-line>, <country>Italy</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Clinical Science and Translational Medicine and School of Sports Medicine, University Tor Vergata</institution>, <addr-line>Rome</addr-line>, <country>Italy</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Physical and Rehabilitation Medicine, Tor Vergata University</institution>, <addr-line>Rome</addr-line>, <country>Italy</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Medical Oncology Unit, Department of Systems Medicine, Tor Vergata University Hospital</institution>, <addr-line>Rome</addr-line>, <country>Italy</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>Breast Unit, Department of Surgical Science, PTV Policlinico Tor Vergata University</institution>, <addr-line>Rome</addr-line>, <country>Italy</country>
</aff>
<aff id="aff6">
<sup>6</sup>
<institution>School of Specialization in Medical Oncology, University of Messina</institution>, <addr-line>Messina</addr-line>, <country>Italy</country>
</aff>
<aff id="aff7">
<sup>7</sup>
<institution>Department of Biomedical and Dentistry Sciences and Morphological and Functional Imaging, University of Messina</institution>, <addr-line>Messina</addr-line>, <country>Italy</country>
</aff>
<aff id="aff8">
<sup>8</sup>
<institution>Istituto Nazionale Tumori di Napoli, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) &#x201c;G. Pascale&#x201d;</institution>, <addr-line>Napoli</addr-line>, <country>Italy</country>
</aff>
<aff id="aff9">
<sup>9</sup>
<institution>Department of Systems Medicine, University of Rome Tor Vergata</institution>, <addr-line>Rome</addr-line>, <country>Italy</country>
</aff>
<aff id="aff10">
<sup>10</sup>
<institution>UOSD Nephrology and Dialysis, Policlinico Tor Vergata</institution>, <addr-line>Rome</addr-line>, <country>Italy</country>
</aff>
<aff id="aff11">
<sup>11</sup>
<institution>Department of Health Science, University of Basilicata</institution>, <addr-line>Potenza</addr-line>, <country>Italy</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Sharon R. Pine, University of Colorado Anschutz Medical Campus, United States</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Caitlin Fox-Harding, Edith Cowan University, Australia</p>
<p>Mathias Poussel, Centre Hospitalier Universitaire de Nancy, France</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Massimiliano Berretta, <email xlink:href="mailto:berrettama@gmail.com">berrettama@gmail.com</email>; Oreste Claudio Buonomo, <email xlink:href="mailto:o.buonomo@inwind.it">o.buonomo@inwind.it</email>
</p>
</fn>
<fn fn-type="other" id="fn003">
<p>&#x2020;These authors share first authorship</p>
</fn>
<fn fn-type="other" id="fn004">
<p>&#x2021;These authors share last authorship</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>09</day>
<month>08</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>14</volume>
<elocation-id>1407919</elocation-id>
<history>
<date date-type="received">
<day>17</day>
<month>04</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>24</day>
<month>07</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2024 Berretta, Garozzo, Foti, Roselli, Materazzo, Vita, Iellamo, Scordari, Di Mauro, Spatari, Ottaiano, Noce, Pellicciaro, Bignucolo, Vanni and Buonomo</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Berretta, Garozzo, Foti, Roselli, Materazzo, Vita, Iellamo, Scordari, Di Mauro, Spatari, Ottaiano, Noce, Pellicciaro, Bignucolo, Vanni and Buonomo</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Background</title>
<p>Improving prognosis of BC patients has drawn the attention of health care professionals on disease related long-term side effects and on the multiple treatments BC patients must undergo. Despite advances in procedures, surgery still has multiple detrimental effects, including pain, edema, and limited mobility. For this reason, fostering adapted physical activity (APA) and healthy lifestyle (including a balanced diet and weight management) should become an everyday purpose of healthcare professionals. Fencing may be a well-suited activity to counteract fatigue, pain, and limited arm mobility.</p>
</sec>
<sec>
<title>Method and analysis</title>
<p>The FENICE study is a mono-center, randomized clinical trial targeting women with BC stages I-III within four weeks from BC surgery. Participants in the control arm will receive the usual recommendations based on the good clinical practice guidelines. In the study arm, participants will be treated with the usual clinical and therapeutic recommendations together with APA and correct lifestyle suggestions.</p>
</sec>
<sec>
<title>Objective</title>
<p>The primary objective of the study is to compare whether implementation of APA and healthy lifestyle in BC patient after surgery will result in an overall improvement of physical and mental status.</p>
</sec>
<sec>
<title>Conclusion</title>
<p>Fencing and its early application in postoperative period may represent a feasible strategy to be implemented in the rehabilitation journey of BC patients.</p>
</sec>
<sec>
<title>Ethics and dissemination</title>
<p>The study protocol FENICE has been approved by an Italian Ethics Committee on May 2023 (R.S 100.23 5<sup>th</sup> May 2023).</p>
</sec>
</abstract>
<kwd-group>
<kwd>BC</kwd>
<kwd>surgery</kwd>
<kwd>rehabilitation</kwd>
<kwd>fencing</kwd>
<kwd>APA</kwd>
<kwd>multidisciplinary network</kwd>
</kwd-group>
<counts>
<fig-count count="3"/>
<table-count count="4"/>
<equation-count count="0"/>
<ref-count count="56"/>
<page-count count="10"/>
<word-count count="4509"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Breast Cancer</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>Breast cancer (BC) is a growing global public health concern. Over time, different risk factors have been identified: alongside the genetic mutations (most commonly involving BRCA1 and BRCA2) implicated in hereditary form of breast and ovarian cancer, the most important risk factors for the sporadic form include personal and family history of BC, wide fertile window (related to early menarche, older age at menopause, first pregnancy after the age of 30 and nulliparity), the exposure to external sources of hormones (during hormone replacement therapy or using oral contraceptives), dense breast tissue and lifestyle based risk factors as alcohol consumption, tobacco, physical inactivity and sedentary lifestyle  (<xref ref-type="bibr" rid="B1">1</xref>&#x2013;<xref ref-type="bibr" rid="B4">4</xref>). The cancer screening programs in Italy comply with the guidelines established at European level, which are contained in the EU recommendation of December 16, 2003. These guidelines identify the three screening programs (breast, uterine and colorectal cancer) as the most effective cancer prevention measures (<xref ref-type="bibr" rid="B5">5</xref>). Despite the national cancer screening program launched since 2005, BC still affects many women in Italy. According to the latest AIRTUM (Associazione Italiana Registri Tumori) report, almost 56,000 new cases of BC have been diagnosed in our country in 2023, representing 30% of female tumors and 13% of all tumors regardless of gender (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B7">7</xref>). At the same time the survival rate of patients has significantly improved (88% of 5-year survival rate) due to the recent treatments progress and the number of cancer survivors raised from approximately 2 million in 2006 to 3.6 million in 2020 (AIRTUM &#x2013; Associazione Italiana Registri Tumori) (<xref ref-type="bibr" rid="B7">7</xref>). Improving prognosis due to early diagnosis and advances in therapeutic treatments has drawn the attention of health care professionals on disease related long-term side effects and on the multiple treatments BC patients must undergo (<xref ref-type="bibr" rid="B8">8</xref>). However, surgery represents the standard treatment for loco-regional BC, while radiotherapy (RT), antiblastic chemotherapy (AC), target therapy, immunotherapy and endocrine treatment are used in adjuvant and metastatic BC settings. During the past decades, conservative surgery (quadrantectomy) has become the first choice whenever possible, limiting mastectomy in selected cases only. Despite advances in procedures, surgery still has multiple detrimental effects, including pain, edema, and limited mobility (<xref ref-type="bibr" rid="B9">9</xref>&#x2013;<xref ref-type="bibr" rid="B11">11</xref>). Posture very often appears to be compromised after mastectomy because the surgical scar limits arm mobility (e.g., internal rotation and shoulder droop are common, typically causing back pain) (<xref ref-type="bibr" rid="B12">12</xref>). In addition, the removal of lymph nodes (both the sentinel procedure and axillary lymph node dissection) is cited as a common cause of limited mobility and postoperative pain. Moreover, cancer treatments are also responsible of numerous long-term side effects as specified in <xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref> (<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B13">13</xref>&#x2013;<xref ref-type="bibr" rid="B18">18</xref>). Particularly, the use of aromatase inhibitors has been associated with possible risk of arthralgia and bone health worsening (<xref ref-type="bibr" rid="B19">19</xref>, <xref ref-type="bibr" rid="B20">20</xref>). These aspects negatively affect the health-related Quality of Life (QoL) of BC patients (<xref ref-type="bibr" rid="B21">21</xref>, <xref ref-type="bibr" rid="B22">22</xref>). BC patients also reported low levels of Work Ability (WA) and reduced outcomes in terms of employments status, employability, and fitness for work (<xref ref-type="bibr" rid="B23">23</xref>, <xref ref-type="bibr" rid="B24">24</xref>). Some randomized clinical trials (<xref ref-type="bibr" rid="B25">25</xref>, <xref ref-type="bibr" rid="B26">26</xref>) have demonstrated the benefit of regular and appropriate Adapted Physical Activity (APA) during and after BC treatment, particularly in terms of improved health status, strength, QoL and physical function, and fatigue reduction (<xref ref-type="table" rid="T2">
<bold>Table&#xa0;2</bold>
</xref>) (<xref ref-type="bibr" rid="B35">35</xref>, <xref ref-type="bibr" rid="B36">36</xref>). Moreover, two meta-analysis highlighted an inverse relationship between post-diagnosis APA and cancer-related mortality in patients with breast cancer compared to patients practicing low or no physical activity (<xref ref-type="bibr" rid="B37">37</xref>, <xref ref-type="bibr" rid="B38">38</xref>). From another study emerged that patients with ER/PR negative cancer who had been physically active before the diagnosis had a significantly reduced risk for breast cancer recurrence compared to physically inactive patients (<xref ref-type="bibr" rid="B39">39</xref>). In early BC and in metastatic BC setting has been recently demonstrated that physical activity integration is able to improve general and physical well-being and mental health (<xref ref-type="bibr" rid="B40">40</xref>). Accordingly, these non-pharmacological treatments that alleviate long term side effects should be rated as a public health priority, as their role is crucial in improving overall survival (OS) and QoL in BC, cancer survivors included. For this reason, fostering APA and healthy lifestyle (including a balanced Mediterranean diet and weight management) should become an everyday purpose of healthcare professionals (<xref ref-type="bibr" rid="B41">41</xref>). In this context, APA as fencing has proven its affinity and efficacy as a supportive activity both during and after the treatment of BC patients (<xref ref-type="bibr" rid="B30">30</xref>, <xref ref-type="bibr" rid="B35">35</xref>, <xref ref-type="bibr" rid="B42">42</xref>, <xref ref-type="bibr" rid="B43">43</xref>).</p>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>Side effects related to cancer treatments in breast cancer patients.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" align="center">Late Side effects</th>
<th valign="middle" colspan="5" align="center">Type of treatments</th>
</tr>
<tr>
<th valign="middle" align="center"/>
<th valign="middle" align="center">Chemotherapy</th>
<th valign="middle" align="center">Endocrine therapy</th>
<th valign="middle" align="center">Radiotherapy</th>
<th valign="middle" align="center">Surgery</th>
<th valign="middle" align="center">Target Therapy</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" align="left">
<bold>Arthralgia</bold>
</td>
<td valign="middle" align="center">&#x2717;</td>
<td valign="middle" align="center">&#x2713;&#x2713;&#x2713;</td>
<td valign="middle" align="center">&#x2717;</td>
<td valign="middle" align="center">&#x2717;</td>
<td valign="middle" align="center">&#x2717;</td>
</tr>
<tr>
<td valign="middle" align="left">
<bold>Bone health</bold>
</td>
<td valign="middle" align="center">&#x2713;</td>
<td valign="middle" align="center">&#x2713;&#x2713;&#x2713;</td>
<td valign="middle" align="center">&#x2713;</td>
<td valign="middle" align="center">&#x2717;</td>
<td valign="middle" align="center">&#x2717;</td>
</tr>
<tr>
<td valign="middle" align="left">
<bold>Cardiovascular disease</bold>
</td>
<td valign="middle" align="center">&#x2713;&#x2713;</td>
<td valign="middle" align="center">&#x2717;</td>
<td valign="middle" align="center">&#x2713;</td>
<td valign="middle" align="center">&#x2717;</td>
<td valign="middle" align="center">&#x2713;&#x2713;&#x2713;</td>
</tr>
<tr>
<td valign="middle" align="left">
<bold>Depression and anxiety</bold>
</td>
<td valign="middle" align="center">&#x2713;&#x2713;&#x2713;</td>
<td valign="middle" align="center">&#x2713;</td>
<td valign="middle" align="center">&#x2713;&#x2713;</td>
<td valign="middle" align="center">&#x2713;</td>
<td valign="middle" align="center">&#x2713;&#x2713;</td>
</tr>
<tr>
<td valign="middle" align="left">
<bold>Fatigue</bold>
</td>
<td valign="middle" align="center">&#x2713;&#x2713;&#x2713;</td>
<td valign="middle" align="center">&#x2713;</td>
<td valign="middle" align="center">&#x2713;&#x2713;</td>
<td valign="middle" align="center">&#x2717;</td>
<td valign="middle" align="center">&#x2713;&#x2713;</td>
</tr>
<tr>
<td valign="middle" align="left">
<bold>Lymphedema</bold>
</td>
<td valign="middle" align="center">&#x2717;</td>
<td valign="middle" align="center">&#x2717;</td>
<td valign="middle" align="center">&#x2713;</td>
<td valign="middle" align="center">&#x2713;&#x2713;</td>
<td valign="middle" align="center">&#x2717;</td>
</tr>
<tr>
<td valign="middle" align="left">
<bold>Metabolic disturbances</bold>
</td>
<td valign="middle" align="center">&#x2713;</td>
<td valign="middle" align="center">&#x2713;&#x2713;</td>
<td valign="middle" align="center">&#x2717;</td>
<td valign="middle" align="center">&#x2717;</td>
<td valign="middle" align="center">&#x2713;</td>
</tr>
<tr>
<td valign="middle" align="left">
<bold>Neurocognitive dysfunction</bold>
</td>
<td valign="middle" align="center">&#x2713;</td>
<td valign="middle" align="center">&#x2717;</td>
<td valign="middle" align="center">&#x2713;</td>
<td valign="middle" align="center">&#x2717;</td>
<td valign="middle" align="center">&#x2713;</td>
</tr>
<tr>
<td valign="middle" align="left">
<bold>Pain</bold>
</td>
<td valign="middle" align="center">&#x2713;</td>
<td valign="middle" align="center">&#x2717;</td>
<td valign="middle" align="center">&#x2713;&#x2713;</td>
<td valign="middle" align="center">&#x2713;&#x2713;&#x2713;</td>
<td valign="middle" align="center">&#x2717;</td>
</tr>
<tr>
<td valign="middle" align="left">
<bold>Peripheral neuropathy</bold>
</td>
<td valign="middle" align="center">&#x2713;&#x2713;&#x2713;</td>
<td valign="middle" align="center">&#x2717;</td>
<td valign="middle" align="center">&#x2717;</td>
<td valign="middle" align="center">&#x2713;</td>
<td valign="middle" align="center">&#x2717;</td>
</tr>
<tr>
<td valign="middle" align="left">
<bold>Respiratory impairment</bold>
</td>
<td valign="middle" align="center">&#x2713;</td>
<td valign="middle" align="center">&#x2717;</td>
<td valign="middle" align="center">&#x2713;&#x2713;</td>
<td valign="middle" align="center">&#x2717;</td>
<td valign="middle" align="center">&#x2713;</td>
</tr>
<tr>
<td valign="middle" align="left">
<bold>Sexual disfunction</bold>
</td>
<td valign="middle" align="center">&#x2713;</td>
<td valign="middle" align="center">&#x2713;&#x2713;</td>
<td valign="middle" align="center">&#x2717;</td>
<td valign="middle" align="center">&#x2717;</td>
<td valign="middle" align="center">&#x2717;</td>
</tr>
<tr>
<td valign="middle" align="left">
<bold>Shoulder limited mobility</bold>
</td>
<td valign="middle" align="center">&#x2717;</td>
<td valign="middle" align="center">&#x2717;</td>
<td valign="middle" align="center">&#x2713;</td>
<td valign="middle" align="center">&#x2713;&#x2713;</td>
<td valign="middle" align="center">&#x2717;</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>&#x2713;&#x2713;&#x2713;Probably related (data from RCTs); &#x2713;&#x2713;Might be related (data from RCTs with smaller samples); &#x2713;Could be related (single-arm studies); &#x2717;No sufficient data.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="T2" position="float">
<label>Table&#xa0;2</label>
<caption>
<p>Beneficial effects of Adapted Physical Activity in cancer patients.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" align="left">Sport/physical activity</th>
<th valign="middle" align="left">Benefit</th>
<th valign="middle" align="left">Reference</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" align="left">
<bold>Aerobic training</bold>
</td>
<td valign="middle" align="left">
<bold>&#x2193;</bold>CRF, <bold>&#x2191;</bold>health related QoL and physical function, <bold>&#x2193;</bold>anxiety, depression, <bold>&#x2191;</bold>sleep quality.</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B27">27</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">
<bold>Cycling</bold>
</td>
<td valign="middle" align="left">
<bold>&#x2191;</bold>QoL, <bold>&#x2191;</bold>Physical functioning, <bold>&#x2191;</bold>general health, <bold>&#x2191;</bold>vitality.</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B28">28</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">
<bold>Dragon Boat</bold>
</td>
<td valign="middle" align="left">&#x2191;QoL, &#x2191;Physical functioning, &#x2193;fatigue.</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B29">29</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">
<bold>Fencing</bold>
</td>
<td valign="middle" align="left">
<bold>&#x2191;</bold>immunity function, <bold>&#x2191;</bold>adherence to therapies, <bold>&#x2191;</bold>health related QoL, <bold>&#x2193;</bold>CRF, <bold>&#x2193;</bold>anxiety, <bold>&#x2191;</bold>of the functional capacities.</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B30">30</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">
<bold>Resistance training</bold>
</td>
<td valign="middle" align="left">
<bold>&#x2193;</bold>CRF levels, <bold>&#x2191;</bold>health related QoL and physical function, <bold>&#x2193;</bold>lymphedema, <bold>&#x2191;</bold>aspects related to bone health.</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B31">31</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">
<bold>Rowing</bold>
</td>
<td valign="middle" align="left">
<bold>&#x2191;</bold>upper extremity and hip range of motion, <bold>&#x2191;</bold>lower and upper extremity strength, <bold>&#x2191;</bold>aerobic capacity and heart rate at rest and after prolonged effort.</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B32">32</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">
<bold>Swimming</bold>
</td>
<td valign="middle" align="left">
<bold>&#x2191;</bold>Flexion and external rotation of the operated arm.</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B33">33</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">
<bold>Walking</bold>
</td>
<td valign="middle" align="left">
<bold>&#x2193;</bold>Of the BMI, <bold>&#x2193;</bold>breast symptoms and in the arms, <bold>&#x2191;</bold>MS at the extremity of the upper limbs, <bold>&#x2193;</bold>of pain.</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B31">31</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">
<bold>Yoga</bold>
</td>
<td valign="middle" align="left">
<bold>&#x2191;</bold>joint mobility, <bold>&#x2191;</bold>muscle strength, <bold>&#x2191;</bold>QoL.</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B34">34</xref>)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>&#x2193;reduce; &#x2191; improve; CRF, cancer related fatigue; QoL, quality of life; BMI, Body mass index; MS, Muscle Strength.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Fencing can be a good activity to reduce fatigue, pain and limited arm mobility. As it is also a sport that naturally strengthens willpower, practicing fencing can have a positive effect on the attitude and psychological state of participants. Hence, the FENICE study protocol here described will assesses both physical and psychological outcomes.</p>
</sec>
<sec id="s2">
<title>Research hypothesis and objectives</title>
<sec id="s2_1">
<title>Hypothesis</title>
<p>Adapted physical activity along with the introduction of Mediterranean diet and their early application in postoperative period may be a successful strategy to improve the physical and psychological health of BC patients underwent surgery (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>).</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Graphical summary of the primary aim of FENICE trial.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fonc-14-1407919-g001.tif"/>
</fig>
</sec>
<sec id="s2_2">
<title>Primary objective</title>
<p>The primary objective of the study is to compare whether implementation of an APA and healthy lifestyle (Mediterranean diet) will result in an overall improvement of physical and mental status including reduction in the number and severity of clinically relevant adverse events (AEs), in the study group compared with the control group during a 24-month enrollment period.</p>
</sec>
<sec id="s2_3">
<title>Secondary objective</title>
<p>The secondary aim is to compare whether APA improves perception of cancer-related fatigue (CRF) and sleep quality (both measured via specific questionnaires), BMI, bone health, aerobic capacity, heart rate and serum lipid profile in the study arm. In addition, levels of Work Ability as well as health care provider and patient attitudes toward APA as adjunctive therapy will be assessed. Finally, the effect of adapted physical activity and a healthy diet on reducing the recurrence of the disease is being investigated.</p>
</sec>
</sec>
<sec id="s3">
<title>Methods and analysis</title>
<sec id="s3_1">
<title>Adaptation of fencing activity</title>
<p>Considering the high technical component of foil and saber, two fencing specialties, an adapted form of fencing is proposed that allows participants to enjoy the training more. As it is a one-sided sport, participants are encouraged to change the grip of the weapon several times during training in order to use both limbs equally and not to neglect the operated side. To avoid possible complications, low weight foil and saber are used within the APA. The wide use of parries forces the fencer to make larger movements that allow greater involvement of the shoulder joint to improve the range of movement of the operated arm. The content was developed by the Universit&#xe0; degli Studi di Roma Tor Vergata in collaboration with Daniele Garozzo, specialist in sports medicine and Olympic foil champion; Fabio Maria Galli and Lucio Landi, foil, and saber coaches of Olympic fencers, respectively. From an athletic performance perspective, it must be considered a moderate-intensity physical activity (i.e., participants feel increased heart rate, respiration, and body temperature, but are still able to carry on a conversation), with the added benefit of being safe, psychologically engaging, fun, and social to encourage broad participation and minimal dropout (<xref ref-type="bibr" rid="B44">44</xref>).</p>
</sec>
<sec id="s3_2">
<title>Design of FENICE trial</title>
<p>The FENICE study is a mono-center, randomized clinical trial targeting women with stages I-III BC within four weeks from surgery, conducted at the Breast Unit of Policlinico Tor Vergata Rome and Frascati Scherma ASD. The sequence of study and control group is randomized to minimize the influence of time-dependent variables. The participants, regardless of arm dominance, will be followed up by oncologists, radiotherapists, and surgeons according to the BC guidelines. All subjects participating in the study will undergo a sports medicine examination to objectify whether there are any alterations or diseases that pose a risk to the patient and to determine whether the patient needs to have additional tests and more specific examinations performed. For participants in the study arm only, APA consists of two fencing sessions (1 h/session) per week within 15 days of enrollment. The minimum number of sessions for the assessment of the primary endpoint is 48 sessions over six months up to a maximum of 96 sessions over 12 months (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2</bold>
</xref>).</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Study design of the mono center randomized FENICE clinical trial. All screened patients will receive a complete clinical, psychological, and instrumental evaluation, (lifestyle, comorbidities, oncological treatments and their related sequelae and AEs). Participants in the control arm will receive the usual recommendations based on the good clinical practice guidelines and according to 1) the stage of BC disease; 2) planned oncological treatments; 3) sequelae and AEs caused by oncological treatments. In the study arm, participants will be treated with the usual clinical and therapeutic recommendations together with APA and correct lifestyle suggestions (Mediterranean diet). All participants will be followed up for a minimum of 12 month, and up to a maximum of 24 months.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fonc-14-1407919-g002.tif"/>
</fig>
<p>After a warm-up period dedicated to muscle awakening and progressive cardio-respiratory stress, participants begin specific fencing exercises, starting with basic footwork (advance, retreat, lunge) and ending with actions in which the injured side holds the saber. During the main activity (40 minutes of fencing), exercise intensity will be individually tailored based on a preliminary assessment. All participants will undergo an exercise stress test on a cycle ergometer during the recruitment phase of the study. This test will measure key physiological parameters, including heart rate, oxygen consumption (V&#x2019;O2), and the MET (Metabolic Equivalent of Task) values achieved (<xref ref-type="bibr" rid="B45">45</xref>). The MET value, which represents the energy cost of physical activities, will be used to calibrate the intensity of physical exertion during training sessions. Specifically, the fencing exercises will be designed to reach an intensity that is approximately 60-70% of the participants&#x2019; maximal MET values determined during the stress test. This range corresponds to moderate-intensity exercise, which has been shown to be effective in improving cardiovascular fitness and overall health. Additionally, to ensure safety and maximize adherence, participants&#x2019; heart rates will be monitored during training to maintain the desired intensity. The target heart rate zone will be calculated using the Karvonen formula, which considers the participants&#x2019; resting heart rates and the intensity percentage derived from their stress test results. This individualized approach ensures that participants engage at a cardio-respiratory intensity that is challenging yet enjoyable. They will be encouraged to maintain a level of exertion where they can still respond verbally (the &#x201c;talk test&#x201d;), indicating they are working within a safe and effective moderate-intensity zone (<xref ref-type="bibr" rid="B46">46</xref>&#x2013;<xref ref-type="bibr" rid="B48">48</xref>).</p>
<p>Adapted fencing includes offensive and defensive actions, which are performed considering the mobility of the shoulder. The primary (tierce = outside; quart = inside; fifth = head) and secondary blocks are therefore performed by patients with maximum mobility, without ever causing pain. Coordination, agility, and strength are encouraged during exercises between patients and during lessons with the fencing master. The adapted fencing lesson ends with a cool-down period. Since different subjects experience different physical outcomes for the cancer and the subsequent treatment, the program must address these individual needs while respecting safety principles. Therefore, rest and water breaks will be provided when necessary, and simplified or less strenuous movements will be suggested as alternatives for those who find parts of the workout too challenging or unsafe. In addition, participants are encouraged to use both saber and foil, also depending on which master is holding the training session. In any case, the weapons used will be adapted in material to avoid excessive strain or fatigue as stated above. Moreover, the courses and masters allow 12 participants per session with a maximum ratio of 1 master per 2.5 participants. During the study protocol, participants are also encouraged to follow healthy diet and adhere to the standards of the Mediterranean diet through the prescription of a personalized diet by a nutritional biologist involved in the project. Conventional bioelectrical impedance (BIA) testing to assess body composition is also planned during protocol follow-ups. To assess adherence to the Mediterranean diet, the Prevenci&#xf3;n con Dieta Mediterr&#xe1;nea (PREDIMED) questionnaire will be completed both at the beginning and at the end of the study (<xref ref-type="bibr" rid="B49">49</xref>). The participants of the FENICE study will be followed up by several specialists before and during the APA period (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3</bold>
</xref>). This study was approved by the ethic board of the Policlinico Tor Vergata of Univeristy of Rome and the enrollment will start in September 2024 and the recruitment will take an 18 months&#x2019; time window for the inclusion of the expected 150 participants.</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>Specialists composing the multidisciplinary team of the FENICE clinical trial. Each BC patient enrolled in the study arm will be evaluated and monthly followed up by specialists before and during the adapted fencing activity.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fonc-14-1407919-g003.tif"/>
</fig>
</sec>
<sec id="s3_3">
<title>Inclusion and exclusion criteria</title>
<p>The inclusion and exclusion criteria for the FENICE trial are listed in <xref ref-type="table" rid="T3">
<bold>Table&#xa0;3</bold>
</xref>.</p>
<table-wrap id="T3" position="float">
<label>Table&#xa0;3</label>
<caption>
<p>Inclusion and exclusion criteria.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="center">Inclusion criteria</th>
<th valign="top" align="center">Exclusion criteria</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">The subject, at the time of diagnosis, must be between 18 and 70 years old</td>
<td valign="top" align="left">Subjects with recurrence of BC and treated with surgery, chemotherapy, radiotherapy, and hormone therapy</td>
</tr>
<tr>
<td valign="top" align="left">Subject affected by non-metastatic BC and treated with surgery for primary tumor</td>
<td valign="top" align="left">Life expectancy estimated to be less than three months by treating clinical team</td>
</tr>
<tr>
<td valign="top" align="left">Subject is able and willing to take part and be followed-up for at least 24 weeks</td>
<td valign="top" align="left">Unable and unwilling to consent to the study</td>
</tr>
<tr>
<td valign="top" align="left">Subject can carry out Adapted Physical Activity</td>
<td valign="top" align="left">Subject is, in the opinion of the Investigator, not suitable to participate in the study (e.g. surgical outcomes, severe co-morbidities, osteoporosis)</td>
</tr>
<tr>
<td valign="top" align="left">Subject has signed informed consent</td>
<td valign="top" align="left">Patient has existing impaired hepatic, renal or cardiorespiratory, Lymphatic function for which Adapted Physical Activity is contraindicated</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s3_4">
<title>Recruitment and study population</title>
<p>Patients of any ethnicity who are at least 18 years old with diagnosis of non-metastatic BC and already treated with surgery for primary tumor are eligible. The recruiting physicians will check the in- and exclusion criteria and determine whether the patient is eligible for participation (see <xref ref-type="table" rid="T3">
<bold>Table&#xa0;3</bold>
</xref>). Participation in the FENICE study is on a voluntary basis. Participants will be informed about the aims of the study both verbally and in writing and will have the opportunity to ask questions and refuse participation.</p>
</sec>
<sec id="s3_5">
<title>Ethical considerations</title>
<p>The study will determine which group between subjects practicing APA and following Mediterranean diet (study arm) and those following the normal BC guidelines (standard of care) will benefit the most. Written informed consent, approved by an Italian Ethics Committee (R.S 100.23 5<sup>th</sup> May 2023), will be obtained from each participant. Health complications for the participants will be addressed by the multidisciplinary team involved in the research and, if necessary, by contacting the patients&#x2019; MMG. If any complications that endanger the patient&#x2019;s health, should arise the participant will be asked to withdraw from the study. Finally, subjects can leave the study at any time for any reason without any consequences, and, likewise, the research physicians can decide to withdraw a subject from the study for urgent medical reasons.</p>
</sec>
<sec id="s3_6">
<title>Follow up visits</title>
<p>Participants will be included in the FENICE study for a total of 24 months and will be followed up differently based on the inclusion arm. In the study arm (APA and Mediterranean diet arm) patients will be monthly followed up for comorbidities, co-medication and herbal remedies, adverse events, and body mass index (BMI). Moreover, every three months also clinical evaluation, blood parameters, instrumental exams and QoL questionnaires will be carried out for the study arm patients. In the control arm, instead, all the mentioned parameters will be followed up every three months (see <xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2</bold>
</xref>).</p>
</sec>
<sec id="s3_7">
<title>Data collection</title>
<p>Participants will be included in the study and will undergo several follow-up visits. During the follow-up period trained research nurses/data managers will contact patients at baseline (T=0) (&#xb1; one week), and subsequently every four weeks (&#xb1; two weeks), to go through a standardized questionnaire and to collect data on the outcomes of sequelae and clinical symptoms/AEs. In addition, all patients will be contacted by the research nurse/data manager at the end of the APA period (&#xb1; two weeks from the end) to complete a last questionnaire. Research nurses/data managers additionally will collect required laboratory and or test results from participants&#x2019; (electronic) medical records. If a subject discontinues the APA and lifestyle interventions during the 12-week follow-up period, follow-up will continue.</p>
<p>The questions within the surveys will be performed to assess the occurrence and severity of any new symptoms experienced by the participants, and the global physical and psychological health after the beginning of APA. The questionnaires that will be administered to participants during the study period are listed in <xref ref-type="table" rid="T4">
<bold>Table&#xa0;4</bold>
</xref>.</p>
<table-wrap id="T4" position="float">
<label>Table&#xa0;4</label>
<caption>
<p>Type of questionnaire that will be administered to breast cancer patients.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left">Objective</th>
<th valign="top" align="left">Questionnaire</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">
<bold>Disability</bold>
</td>
<td valign="top" align="left">The DASH (disabilities of the arm, shoulder, and hand measurement tool) questionnaire</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>QoL</bold>
</td>
<td valign="top" align="left">EORTC qlq-C30 and EORTC qlq- BR23 questionnaire</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>Fatigue</bold>
</td>
<td valign="top" align="left">The MFI 20 (Multidimensional fatigue inventory) questionnaire</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>Anxiety-depression</bold>
</td>
<td valign="top" align="left">The HADS (Hospital anxiety and depression scale) questionnaire</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>Physical activity and sedentary behavior</bold>
</td>
<td valign="top" align="left">The short version of the IPAQ (international physical activity questionnaire)</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>Oedema assessment</bold>
</td>
<td valign="top" align="left">Disability scale for oedema</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s3_8">
<title>Sample size</title>
<p>The hypothesis guiding the formal determination of the sample size proposes an expected improvement of at least 15 points in the mean DASH score. The DASH score is a valuable, pragmatic, and frequently utilized metric in individuals with various musculoskeletal disorders of the upper limb. Ranging from 0 to 100, it encompasses responses to 30 questions (<ext-link ext-link-type="uri" xlink:href="https://orthotoolkit.com/dash/">https://orthotoolkit.com/dash/</ext-link>) An improvement of at least 15 points is considered clinically significant in enhancing functional ability. The statistical parameters are configured in a highly conservative manner, considering the non-pharmacological nature of the intervention (adapted physical activity) and the inherent inter-individual variability in response, particularly within the treated group (Group 1). Therefore, with alpha and beta errors set at 0.01, a standard deviation in Group 1 that is twice that of Group 2 (SD: 20 compared to 10), even exceeding the hypothesized difference (15 points), 56 patients per group are deemed necessary. Considering the enrollment capabilities of our group and potential physiological withdrawal of patients, the sample size has been increased to 150 total patients. The target population will be at least 18 years of age (of any ethnicity) with a diagnosis of non-metastatic breast cancer and already treated with surgery for the primary tumor. This total will be divided into two sub-groups by randomization in blocks of 75 patients each (intervention group, Group 1, and control group, Group 2). The first group will be distinguished by subjects treated with adapted physical activity rehabilitation and with correct lifestyle suggestions. The second group, on the other hand, will be characterized by standard care without physical activity rehabilitation or lifestyle suggestions.</p>
</sec>
<sec id="s3_9">
<title>Statistical analysis</title>
<p>The descriptive statistical analyses, the central tendency, variability, symmetry and kurtosis will be calculated, all accompanied by appropriate graphical representations. Regarding the inferential analyses, we will continue with the verification of the parametric and non-parametric hypotheses, respectively for the quantitative variables with parametric tests such as: Student&#x2019;s t-test, Fisher&#x2019;s F-test, etc. and for categorical variables using non-parametric tests such as: chi-square, Mann Wittney&#x2019;s U, Fisher&#x2019;s exact test, etc. Only results with p-values &#x2264; 0.05 will be considered statistically significant. Principal component analysis (PCA) will be adopted to explore the relationships among secondary variables and identify patterns of improvement related to the APA intervention (<xref ref-type="bibr" rid="B50">50</xref>).</p>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<title>Discussion</title>
<p>Regular physical activity performed during and after a BC treatment has been shown to improve quality of life (QoL) (<xref ref-type="bibr" rid="B34">34</xref>, <xref ref-type="bibr" rid="B35">35</xref>). However, the type of exercise and the time spent on it are still based on patient&#x2019;s will. Recently, a rehabilitation program was launched in France for women treated for BC that used adapted fencing as a rehabilitative activity. The RIPOSTE program aimed to offer adapted fencing to patients with BC (<xref ref-type="bibr" rid="B30">30</xref>, <xref ref-type="bibr" rid="B43">43</xref>). In Italy, several authorities, including scientific associations (LILT &#x2013; Lega Italiana per la Lotta ai Tumori), sports federations and Institutions (FIS &#x2013; Federazione Italiana Scherma, CONI &#x2013; Comitato Olimpico Nazionale Italiano) are committed to raising awareness of cancer patients and physicians on APA, diet, and correct lifestyle, throughout the promotion of observational studies, sporting, and popular events (&#x201c;Nastro rosa&#x201d;, &#x201c;rema Roma per la vita&#x201d;). With the FENICE study protocol, the initiative is intended to introduce the discipline of fencing into the rehabilitation program for women who have undergone surgery for breast cancer. Usually, after surgery, there is excessive internal rotation of the shoulder, which affects the patient&#x2019;s posture, and fencing, especially the guard position, promotes an improvement of this condition. In addition, the range of motion resulting from increasingly higher parries under the guidance of the fencing master promotes the mobility of the arm and shoulder, which are limited by surgical scars and adhesions. The laterality of the exercise and the type of weapons used (foil and saber) allow constant work on mobilizing the operated shoulder and arm, especially since it is an upper-body activity that focuses on the upper body, from the belt to the head. (<xref ref-type="bibr" rid="B30">30</xref>, <xref ref-type="bibr" rid="B43">43</xref>). Finally, the strong concentration and determination that fencing requires will certainly have a positive effect on image, mood, and mental strength, which are very often compromised following breast surgery. We firmly believe that the FENICE study by introducing adapted fencing in the near postoperative period, can be an effective tool to improve the physical and mental health of patients who have undergone surgery for BC. To date, the importance of adapted physical activity as a rehabilitation measure is emphasized in the literature, especially for cancer patients. In Italy, however, APA remains limited to local initiatives without being promoted by the health authorities. In some countries, such as France and the United Kingdom, APA is recognized as a prescription treatment for chronic diseases. As APA is therefore reimbursed by the health system, the sports doctor can prescribe a physical rehabilitation activity such as a medication or an examination. We hope that the FENICE protocol will be a pilot study for large-scale clinical trials that can lay the foundations for nationwide recognition of APA in the Italian healthcare system. Alongside the key role of the sports physician in APA implementation, this initiative might shed light on the role of physical activity and rehabilitation in improving WA of breast cancer patients since data from the literature are to date inconsistent (<xref ref-type="bibr" rid="B51">51</xref>). Currently, there is a lack of uniform and shared guidelines that can evaluate the Work Ability Index (WAI) through interventions or rehabilitative activities that support the patient&#x2019;s return to work or, possibly, retention. Recently, the &#x201c;Beyond Cancer&#x201d; program by Sheppard and colleagues tried to overcome these barriers to sustainable return to work for women with breast cancer (<xref ref-type="bibr" rid="B52">52</xref>). In that perspective the FENICE study, as a tailored occupational rehabilitation intervention, may also include in its multidisciplinary network occupational physicians to assess the actual benefit of PA in promoting patients&#x2019; return to work and employability through dedicated questionnaires for participants in the adapted fencing group.</p>
</sec>
<sec id="s5" sec-type="conclusions">
<title>Conclusion</title>
<p>In summary, the FENICE study protocol aims to introduce adapted Fencing and Mediterranean diet habits as suitable methods of postoperative BC rehabilitation. This innovative APA will be performed on 75 BC participants who will be closely followed by a multidisciplinary team of oncologists, physiatrists, nutritional biologists, radiotherapists, surgeons, cardiologists, gynecologists, psychologists, and Olympic fencing masters. We hypothesize successful adapted Fencing could improve BC patients&#x2019; physical status by reducing upper limb lymphedema and promoting a wider mobility of the operated limb. In addition to the physical improvement, the dietary recommendations (Mediterranean diet) together with workouts will positively affect patients&#x2019; lipid profile and the ratio of fat-free mass to fat mass. This study fits fully into the context of integrative and complementary medicine, which is increasingly finding a place in the care of the cancer patient. Together with the use of the most common biological CAMs (e.g., herbal products or botanicals, vitamins, minerals, probiotics, homeopathic products, and Chinese herbal remedies), also APA and proper nutrition (Mediterranean diet) fall into the large category of non-biological CAMs (<xref ref-type="bibr" rid="B53">53</xref>&#x2013;<xref ref-type="bibr" rid="B56">56</xref>). The FENICE study protocol will be a further confirmation of an integrated approach to cancer treatment that requires multidisciplinary work and in-depth knowledge of this broad area.</p>
</sec>
<sec id="s6" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>The studies involving humans were approved byItalian Ethics Committee (R.S 100.23 5th May 2023); ethic board of the Policlinico Tor Vergata of Univeristy of Rome. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.</p>
</sec>
<sec id="s7" sec-type="author-contributions">
<title>Author contributions</title>
<p>MB: Conceptualization, Visualization, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing, Methodology. DG: Conceptualization, Visualization, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing, Methodology. CF: Conceptualization, Visualization, Writing &#x2013; review &amp; editing. MR: Conceptualization, Visualization, Writing &#x2013; review &amp; editing. MM: Visualization, Writing &#x2013; review &amp; editing. GVi: Visualization, Writing &#x2013; review &amp; editing. FI: Visualization, Writing &#x2013; review &amp; editing. MS: Visualization, Writing &#x2013; review &amp; editing. GD: Visualization, Writing &#x2013; review &amp; editing. GS: Methodology, Visualization, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing. AO: Methodology, Visualization, Writing &#x2013; review &amp; editing. AN: Visualization, Writing &#x2013; review &amp; editing. MP: Visualization, Writing &#x2013; review &amp; editing. AB: Methodology, Visualization, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing. GVa: Methodology, Visualization, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing. OB: Conceptualization, Visualization, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing.</p>
</sec>
</body>
<back>
<sec id="s8" sec-type="funding-information">
<title>Funding</title>
<p>The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.</p>
</sec>
<ack>
<title>Acknowledgments</title>
<p>We thank the Italian Fencing Federation, president Giorgio Scarso and Cinzia Sacchetti for implementing the &#x201c;Nastro Rosa&#x201d; project, and President Paolo Azzi and Vincenzo De Bartolomeo for promoting the FENICE study.</p>
</ack>
<sec id="s9" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
<p>The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.</p>
</sec>
<sec id="s10" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cappellani</surname> <given-names>A</given-names>
</name>
<name>
<surname>Di Vita</surname> <given-names>M</given-names>
</name>
<name>
<surname>Zanghi</surname> <given-names>A</given-names>
</name>
<name>
<surname>Cavallaro</surname> <given-names>A</given-names>
</name>
<name>
<surname>Piccolo</surname> <given-names>G</given-names>
</name>
<name>
<surname>Veroux</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Diet, obesity and breast cancer: an update</article-title>. <source>Front Biosci (Schol Ed)</source>. (<year>2012</year>) <volume>4</volume>:<fpage>90</fpage>&#x2013;<lpage>108</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.2741/s253</pub-id>
</citation>
</ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Caputo</surname> <given-names>R</given-names>
</name>
<name>
<surname>Cianniello</surname> <given-names>D</given-names>
</name>
<name>
<surname>Giordano</surname> <given-names>A</given-names>
</name>
<name>
<surname>Piezzo</surname> <given-names>M</given-names>
</name>
<name>
<surname>Riemma</surname> <given-names>M</given-names>
</name>
<name>
<surname>Trov&#xf2;</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Gene expression assay in the management of early breast cancer</article-title>. <source>Curr Medicinal Chem</source>. (<year>n.</year>) <volume>27</volume>:<page-range>2826&#x2013;39</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.2174/0929867326666191205163329</pub-id>
</citation>
</ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goodarzi</surname> <given-names>E</given-names>
</name>
<name>
<surname>Beiranvand</surname> <given-names>R</given-names>
</name>
<name>
<surname>Naemi</surname> <given-names>H</given-names>
</name>
<name>
<surname>Pordanjani</surname> <given-names>SR</given-names>
</name>
<name>
<surname>Khazaei</surname> <given-names>Z</given-names>
</name>
</person-group>. <article-title>Geographical distribution Incidence and Mortality of Breast cancer and its relationship with the Human Development Index (HDI) - an ecology study in 2018</article-title>. <source>WCRJ</source>. (<year>2020</year>) <volume>7</volume>:<elocation-id>e1468</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.32113/wcrj_20201_1468</pub-id>
</citation>
</ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mohamed</surname> <given-names>RF</given-names>
</name>
<name>
<surname>Melek</surname> <given-names>MI</given-names>
</name>
<name>
<surname>Eid</surname> <given-names>S</given-names>
</name>
<name>
<surname>Morsy</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>The correlation between increasing Body Mass Index and the incidence of local recurrence and distant metastasis in breast cancer patients</article-title>. <source>World Cancer Res J</source>. (<year>2023</year>) <volume>10</volume>:<fpage>e2553</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.32113/wcrj_20235_2553</pub-id>
</citation>
</ref>
<ref id="B5">
<label>5</label>
<citation citation-type="web">
<person-group person-group-type="author">
<collab>Cancer screening program EU Recommendation</collab>
</person-group>. (<year>2003</year>). <article-title>Available online at</article-title>: <uri xlink:href="https://eur-lex.europa.eu/legal-content/IT/TXT/?uri=OJ%3AL%3A2003%3A327%3ATOC">https://eur-lex.europa.eu/legal-content/IT/TXT/?uri=OJ%3AL%3A2003%3A327%3ATOC</uri> (Accessed <access-date>6.16.24</access-date>).</citation>
</ref>
<ref id="B6">
<label>6</label>
<citation citation-type="web">
<person-group person-group-type="author">
<collab>Cancer (IARC)</collab>
</person-group>. <article-title>Global cancer observatory</article-title>(<year>2022</year>). Available online at: <uri xlink:href="https://gco.iarc.fr/">https://gco.iarc.fr/</uri> (Accessed <access-date>6.18.24</access-date>).</citation>
</ref>
<ref id="B7">
<label>7</label>
<citation citation-type="web">
<person-group person-group-type="author">
<collab>I numeri del cancro in Italia</collab>
</person-group>. <article-title>Associazione Italiana Registri Tumori</article-title>(<year>2023</year>). Available online at: <uri xlink:href="https://www.registri-tumori.it/cms/pubblicazioni/i-numeri-del-cancro-italia-2023">https://www.registri-tumori.it/cms/pubblicazioni/i-numeri-del-cancro-italia-2023</uri> (Accessed <access-date>6.18.24</access-date>).</citation>
</ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tralongo</surname> <given-names>P</given-names>
</name>
<name>
<surname>Pescarenico</surname> <given-names>MG</given-names>
</name>
<name>
<surname>Surbone</surname> <given-names>A</given-names>
</name>
<name>
<surname>Bordonaro</surname> <given-names>S</given-names>
</name>
<name>
<surname>Berretta</surname> <given-names>M</given-names>
</name>
<name>
<surname>DI Mari</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Physical needs of long-term cancer patients</article-title>. <source>Anticancer Res</source>. (<year>2017</year>) <volume>37</volume>:<page-range>4733&#x2013;46</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.21873/anticanres.11880</pub-id>
</citation>
</ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaya</surname> <given-names>T</given-names>
</name>
<name>
<surname>Karatepe</surname> <given-names>AG</given-names>
</name>
<name>
<surname>G&#xfc;naydn</surname> <given-names>R</given-names>
</name>
<name>
<surname>Yeti&#x15f;</surname> <given-names>H</given-names>
</name>
<name>
<surname>Uslu</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Disability and health-related quality of life after breast cancer surgery: relation to impairments</article-title>. <source>South Med J</source>. (<year>2010</year>) <volume>103</volume>:<fpage>37</fpage>&#x2013;<lpage>41</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/SMJ.0b013e3181c38c41</pub-id>
</citation>
</ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Malicka</surname> <given-names>I</given-names>
</name>
<name>
<surname>Barczyk</surname> <given-names>K</given-names>
</name>
<name>
<surname>Hanuszkiewicz</surname> <given-names>J</given-names>
</name>
<name>
<surname>Skolimowska</surname> <given-names>B</given-names>
</name>
<name>
<surname>Wo&#x17a;niewski</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Body posture of women after breast cancer treatment</article-title>. <source>Ortop Traumatol Rehabil</source>. (<year>2010</year>) <volume>12</volume>:<page-range>353&#x2013;61</page-range>.</citation>
</ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koehler</surname> <given-names>LA</given-names>
</name>
<name>
<surname>Blaes</surname> <given-names>AH</given-names>
</name>
<name>
<surname>Haddad</surname> <given-names>TC</given-names>
</name>
<name>
<surname>Hunter</surname> <given-names>DW</given-names>
</name>
<name>
<surname>Hirsch</surname> <given-names>AT</given-names>
</name>
<name>
<surname>Ludewig</surname> <given-names>PM</given-names>
</name>
</person-group>. <article-title>Movement, function, pain, and postoperative edema in axillary web syndrome</article-title>. <source>Phys Ther</source>. (<year>2015</year>) <volume>95</volume>:<page-range>1345&#x2013;53</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.2522/ptj.20140377</pub-id>
</citation>
</ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rostkowska</surname> <given-names>E</given-names>
</name>
<name>
<surname>Bak</surname> <given-names>M</given-names>
</name>
<name>
<surname>Samborski</surname> <given-names>W</given-names>
</name>
</person-group>. <article-title>Body posture in women after mastectomy and its changes as a result of rehabilitation</article-title>. <source>Adv Med Sci</source>. (<year>2006</year>) <volume>51</volume>:<page-range>287&#x2013;97</page-range>.</citation>
</ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Giacalone</surname> <given-names>A</given-names>
</name>
<name>
<surname>Quitadamo</surname> <given-names>D</given-names>
</name>
<name>
<surname>Zanet</surname> <given-names>E</given-names>
</name>
<name>
<surname>Berretta</surname> <given-names>M</given-names>
</name>
<name>
<surname>Spina</surname> <given-names>M</given-names>
</name>
<name>
<surname>Tirelli</surname> <given-names>U</given-names>
</name>
</person-group>. <article-title>Cancer-related fatigue in the elderly</article-title>. <source>Support Care Cancer</source>. (<year>2013</year>) <volume>21</volume>:<page-range>2899&#x2013;911</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00520-013-1897-1</pub-id>
</citation>
</ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Muraro</surname> <given-names>E</given-names>
</name>
<name>
<surname>Furlan</surname> <given-names>C</given-names>
</name>
<name>
<surname>Avanzo</surname> <given-names>M</given-names>
</name>
<name>
<surname>Martorelli</surname> <given-names>D</given-names>
</name>
<name>
<surname>Comaro</surname> <given-names>E</given-names>
</name>
<name>
<surname>Rizzo</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Local high-dose radiotherapy induces systemic immunomodulating effects of potential therapeutic relevance in oligometastatic breast cancer</article-title>. <source>Front Immunol</source>. (<year>2017</year>) <volume>8</volume>:<elocation-id>1476</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2017.01476</pub-id>
</citation>
</ref>
<ref id="B15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vinante</surname> <given-names>L</given-names>
</name>
<name>
<surname>Avanzo</surname> <given-names>M</given-names>
</name>
<name>
<surname>Furlan</surname> <given-names>C</given-names>
</name>
<name>
<surname>Fiorica</surname> <given-names>F</given-names>
</name>
<name>
<surname>Perin</surname> <given-names>T</given-names>
</name>
<name>
<surname>Militello</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>Ten daily fractions for partial breast irradiation. Long-term results of a prospective phase II trial</article-title>. <source>Breast J</source>. (<year>2019</year>) <volume>25</volume>:<page-range>243&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/tbj.2019.25.issue-2</pub-id>
</citation>
</ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hama</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Tate</surname> <given-names>E</given-names>
</name>
</person-group>. <article-title>Survey on embarrassment of breast cancer patients receiving radiation therapy</article-title>. <source>World Cancer Res J</source>. (<year>2020</year>) <volume>7</volume>:<fpage>e1607</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.32113/wcrj_20207_1607</pub-id>
</citation>
</ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Muzzatti</surname> <given-names>B</given-names>
</name>
<name>
<surname>Cattaruzza</surname> <given-names>N</given-names>
</name>
<name>
<surname>Piccinin</surname> <given-names>M</given-names>
</name>
<name>
<surname>Flaiban</surname> <given-names>C</given-names>
</name>
<name>
<surname>Agostinelli</surname> <given-names>G</given-names>
</name>
<name>
<surname>Berretta</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Cognitive function in long-term lymphoma survivors: relationship between subjective reports and objective assessments and with quality of life</article-title>. <source>Psychol Health Med</source>. (<year>2021</year>) <volume>26</volume>:<page-range>968&#x2013;79</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/13548506.2020.1770815</pub-id>
</citation>
</ref>
<ref id="B18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yehya</surname> <given-names>A</given-names>
</name>
<name>
<surname>Alshari</surname> <given-names>O</given-names>
</name>
<name>
<surname>Alameri</surname> <given-names>O</given-names>
</name>
<name>
<surname>Albals</surname> <given-names>D</given-names>
</name>
<name>
<surname>Al-Taani</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>Pre-pharmacological management: bi-screening for depression among breast cancer patients</article-title>. <source>World Cancer Res J</source>. (<year>2022</year>) <volume>9</volume>:<fpage>e2233</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.32113/wcrj_20223_2233</pub-id>
</citation>
</ref>
<ref id="B19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Camejo</surname> <given-names>N</given-names>
</name>
<name>
<surname>Castillo</surname> <given-names>C</given-names>
</name>
<name>
<surname>Santana</surname> <given-names>D</given-names>
</name>
<name>
<surname>Argenzio</surname> <given-names>L</given-names>
</name>
<name>
<surname>Amarillo</surname> <given-names>D</given-names>
</name>
<name>
<surname>Herrera</surname> <given-names>G</given-names>
</name>
<etal/>
</person-group>. <article-title>Arthralgia and myalgia associated with aromatase inhibitors: frequency and characterization in real-life patients</article-title>. <source>Ecancermedicalscience</source>. (<year>2024</year>) <volume>18</volume>:<elocation-id>1697</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3332/ecancer.2024.1697</pub-id>
</citation>
</ref>
<ref id="B20">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cerulli</surname> <given-names>C</given-names>
</name>
<name>
<surname>Moretti</surname> <given-names>E</given-names>
</name>
<name>
<surname>Grazioli</surname> <given-names>E</given-names>
</name>
<name>
<surname>Emerenziani</surname> <given-names>GP</given-names>
</name>
<name>
<surname>Murri</surname> <given-names>A</given-names>
</name>
<name>
<surname>Tranchita</surname> <given-names>E</given-names>
</name>
<etal/>
</person-group>. <article-title>Protective role of exercise on breast cancer-related osteoporosis in women undergoing aromatase inhibitors: a narrative review</article-title>. <source>Bone Rep</source>. (<year>2024</year>) <volume>21</volume>:<elocation-id>101756</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.bonr.2024.101756</pub-id>
</citation>
</ref>
<ref id="B21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Browall</surname> <given-names>M</given-names>
</name>
<name>
<surname>Ahlberg</surname> <given-names>K</given-names>
</name>
<name>
<surname>Karlsson</surname> <given-names>P</given-names>
</name>
<name>
<surname>Danielson</surname> <given-names>E</given-names>
</name>
<name>
<surname>Persson</surname> <given-names>L-O</given-names>
</name>
<name>
<surname>Gaston-Johansson</surname> <given-names>F</given-names>
</name>
</person-group>. <article-title>Health-related quality of life during adjuvant treatment for breast cancer among postmenopausal women</article-title>. <source>Eur J Oncol Nurs</source>. (<year>2008</year>) <volume>12</volume>:<page-range>180&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ejon.2008.01.005</pub-id>
</citation>
</ref>
<ref id="B22">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mokhtari-Hessari</surname> <given-names>P</given-names>
</name>
<name>
<surname>Montazeri</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Health-related quality of life in breast cancer patients: review of reviews from 2008 to 2018</article-title>. <source>Health Qual Life Outcomes</source>. (<year>2020</year>) <volume>18</volume>:<fpage>338</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12955-020-01591-x</pub-id>
</citation>
</ref>
<ref id="B23">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Hong</surname> <given-names>BY</given-names>
</name>
<name>
<surname>Kennedy</surname> <given-names>SA</given-names>
</name>
<name>
<surname>Chang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Hong</surname> <given-names>CJ</given-names>
</name>
<name>
<surname>Craigie</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Predictors of unemployment after breast cancer surgery: a systematic review and meta-analysis of observational studies</article-title>. <source>J Clin Oncol</source>. (<year>2018</year>) <volume>36</volume>:<page-range>1868&#x2013;79</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1200/JCO.2017.77.3663</pub-id>
</citation>
</ref>
<ref id="B24">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gregorowitsch</surname> <given-names>ML</given-names>
</name>
<name>
<surname>Bongard</surname> <given-names>HJGD</given-names>
</name>
<name>
<surname>van den</surname> <given-names>AM,C</given-names>
</name>
<name>
<surname>Young-Afat</surname> <given-names>DA</given-names>
</name>
<name>
<surname>Haaring</surname> <given-names>C</given-names>
</name>
<name>
<surname>Dalen</surname> <given-names>TV</given-names>
</name>
<etal/>
</person-group>. <article-title>Self-reported work ability in breast cancer survivors; a prospective cohort study in the Netherlands</article-title>. <source>Breast</source>. (<year>2019</year>) <volume>48</volume>:<fpage>45</fpage>&#x2013;<lpage>53</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.breast.2019.08.004</pub-id>
</citation>
</ref>
<ref id="B25">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mishra</surname> <given-names>SI</given-names>
</name>
<name>
<surname>Scherer</surname> <given-names>RW</given-names>
</name>
<name>
<surname>Geigle</surname> <given-names>PM</given-names>
</name>
<name>
<surname>Berlanstein</surname> <given-names>DR</given-names>
</name>
<name>
<surname>Topaloglu</surname> <given-names>O</given-names>
</name>
<name>
<surname>Gotay</surname> <given-names>CC</given-names>
</name>
<etal/>
</person-group>. <article-title>Exercise interventions on health-related quality of life for cancer survivors</article-title>. <source>Cochrane Database Syst Rev</source>. (<year>2012</year>) <volume>2012</volume>:<fpage>CD007566</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/14651858.CD007566.pub2</pub-id>
</citation>
</ref>
<ref id="B26">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Manneville</surname> <given-names>F</given-names>
</name>
<name>
<surname>Rotonda</surname> <given-names>C</given-names>
</name>
<name>
<surname>Conroy</surname> <given-names>T</given-names>
</name>
<name>
<surname>Bonnetain</surname> <given-names>F</given-names>
</name>
<name>
<surname>Guillemin</surname> <given-names>F</given-names>
</name>
<name>
<surname>Omorou</surname> <given-names>AY</given-names>
</name>
</person-group>. <article-title>The impact of physical activity on fatigue and quality of life during and after adjuvant treatment for breast cancer</article-title>. <source>Cancer</source>. (<year>2018</year>) <volume>124</volume>:<fpage>797</fpage>&#x2013;<lpage>806</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/cncr.31108</pub-id>
</citation>
</ref>
<ref id="B27">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Campbell</surname> <given-names>KL</given-names>
</name>
<name>
<surname>Winters-Stone</surname> <given-names>KM</given-names>
</name>
<name>
<surname>Wiskemann</surname> <given-names>J</given-names>
</name>
<name>
<surname>May</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Schwartz</surname> <given-names>AL</given-names>
</name>
<name>
<surname>Courneya</surname> <given-names>KS</given-names>
</name>
<etal/>
</person-group>. <article-title>Exercise guidelines for cancer survivors: consensus statement from international multidisciplinary roundtable</article-title>. <source>Med Sci Sports Exerc</source>. (<year>2019</year>) <volume>51</volume>:<page-range>2375&#x2013;90</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1249/MSS.0000000000002116</pub-id>
</citation>
</ref>
<ref id="B28">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McKenzie</surname> <given-names>DC</given-names>
</name>
<name>
<surname>Kalda</surname> <given-names>AL</given-names>
</name>
</person-group>. <article-title>Effect of upper extremity exercise on secondary lymphedema in breast cancer patients: a pilot study</article-title>. <source>J Clin Oncol</source>. (<year>2003</year>) <volume>21</volume>:<page-range>463&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1200/JCO.2003.04.069</pub-id>
</citation>
</ref>
<ref id="B29">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Giganti</surname> <given-names>MG</given-names>
</name>
<name>
<surname>Tresoldi</surname> <given-names>I</given-names>
</name>
<name>
<surname>Sorge</surname> <given-names>R</given-names>
</name>
<name>
<surname>Melchiorri</surname> <given-names>G</given-names>
</name>
<name>
<surname>Triossi</surname> <given-names>T</given-names>
</name>
<name>
<surname>Masuelli</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>Physical exercise modulates the level of serum MMP-2 and MMP-9 in patients with breast cancer</article-title>. <source>Oncol Lett</source>. (<year>2016</year>) <volume>12</volume>:<page-range>2119&#x2013;26</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3892/ol.2016.4887</pub-id>
</citation>
</ref>
<ref id="B30">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Omorou</surname> <given-names>AY</given-names>
</name>
<name>
<surname>Peiffert</surname> <given-names>D</given-names>
</name>
<name>
<surname>Rotonda</surname> <given-names>C</given-names>
</name>
<name>
<surname>Van Hoye</surname> <given-names>A</given-names>
</name>
<name>
<surname>Allado</surname> <given-names>E</given-names>
</name>
<name>
<surname>Hily</surname> <given-names>O</given-names>
</name>
<etal/>
</person-group>. <article-title>Adapted fencing for patients with invasive breast cancer: the RIPOSTE pilot randomized controlled trial</article-title>. <source>Front Sports Act Living</source>. (<year>2022</year>) <volume>4</volume>:<elocation-id>786852</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fspor.2022.786852</pub-id>
</citation>
</ref>
<ref id="B31">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bloomquist</surname> <given-names>K</given-names>
</name>
<name>
<surname>Adamsen</surname> <given-names>L</given-names>
</name>
<name>
<surname>Hayes</surname> <given-names>SC</given-names>
</name>
<name>
<surname>Lillelund</surname> <given-names>C</given-names>
</name>
<name>
<surname>Andersen</surname> <given-names>C</given-names>
</name>
<name>
<surname>Christensen</surname> <given-names>KB</given-names>
</name>
<etal/>
</person-group>. <article-title>Heavy-load resistance exercise during chemotherapy in physically inactive breast cancer survivors at risk for lymphedema: a randomized trial</article-title>. <source>Acta Oncol</source>. (<year>2019</year>) <volume>58</volume>:<page-range>1667&#x2013;75</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/0284186X.2019.1643916</pub-id>
</citation>
</ref>
<ref id="B32">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gavala-Gonz&#xe1;lez</surname> <given-names>J</given-names>
</name>
<name>
<surname>G&#xe1;lvez-Fern&#xe1;ndez</surname> <given-names>I</given-names>
</name>
<name>
<surname>Mercad&#xe9;-Mel&#xe9;</surname> <given-names>P</given-names>
</name>
<name>
<surname>Fern&#xe1;ndez-Garc&#xed;a</surname> <given-names>JC</given-names>
</name>
</person-group>. <article-title>Rowing training in breast cancer survivors: a longitudinal study of physical fitness</article-title>. <source>Int J Environ Res Public Health</source>. (<year>2020</year>) <volume>17</volume>:<elocation-id>4938</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijerph17144938</pub-id>
</citation>
</ref>
<ref id="B33">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Johansson</surname> <given-names>K</given-names>
</name>
<name>
<surname>Hayes</surname> <given-names>S</given-names>
</name>
<name>
<surname>Speck</surname> <given-names>RM</given-names>
</name>
<name>
<surname>Schmitz</surname> <given-names>KH</given-names>
</name>
</person-group>. <article-title>Water-based exercise for patients with chronic arm lymphedema: a randomized controlled pilot trial</article-title>. <source>Am J Phys Med Rehabil</source>. (<year>2013</year>) <volume>92</volume>:<page-range>312&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/PHM.0b013e318278b0e8</pub-id>
</citation>
</ref>
<ref id="B34">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Patsou</surname> <given-names>ED</given-names>
</name>
<name>
<surname>Alexias</surname> <given-names>GD</given-names>
</name>
<name>
<surname>Anagnostopoulos</surname> <given-names>FG</given-names>
</name>
<name>
<surname>Karamouzis</surname> <given-names>MV</given-names>
</name>
</person-group>. <article-title>Effects of physical activity on depressive symptoms during breast cancer survivorship: a meta-analysis of randomised control trials</article-title>. <source>ESMO Open</source>. (<year>2017</year>) <volume>2</volume>:<elocation-id>e000271</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1136/esmoopen-2017-000271</pub-id>
</citation>
</ref>
<ref id="B35">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berretta</surname> <given-names>M</given-names>
</name>
<name>
<surname>Facchini</surname> <given-names>BA</given-names>
</name>
<name>
<surname>Garozzo</surname> <given-names>D</given-names>
</name>
<name>
<surname>Necci</surname> <given-names>V</given-names>
</name>
<name>
<surname>Taibi</surname> <given-names>R</given-names>
</name>
<name>
<surname>Torrisi</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Adapted physical activity for breast cancer patients: shared considerations with two Olympic and world Italian sports champions</article-title>. <source>Eur Rev Med Pharmacol Sci</source>. (<year>2022</year>) <volume>26</volume>:<page-range>5393&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.26355/eurrev_202208_29406</pub-id>
</citation>
</ref>
<ref id="B36">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Foti</surname> <given-names>C</given-names>
</name>
<name>
<surname>Scordari</surname> <given-names>M</given-names>
</name>
<name>
<surname>Vita</surname> <given-names>G</given-names>
</name>
<name>
<surname>Imeshtari</surname> <given-names>A</given-names>
</name>
<name>
<surname>Vanni</surname> <given-names>G</given-names>
</name>
<name>
<surname>Torrisi</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Breast cancer rehabilitation and reconditioning</article-title>. <source>World Cancer Res J</source>. (<year>2023</year>) <volume>10</volume>:<fpage>e2233</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.32113/wcrj_20239_2684</pub-id>
</citation>
</ref>
<ref id="B37">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ibrahim</surname> <given-names>EM</given-names>
</name>
<name>
<surname>Al-Homaidh</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Physical activity and survival after breast cancer diagnosis: meta-analysis of published studies</article-title>. <source>Med Oncol</source>. (<year>2011</year>) <volume>28</volume>:<page-range>753&#x2013;65</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s12032-010-9536-x</pub-id>
</citation>
</ref>
<ref id="B38">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Spei</surname> <given-names>M-E</given-names>
</name>
<name>
<surname>Samoli</surname> <given-names>E</given-names>
</name>
<name>
<surname>Bravi</surname> <given-names>F</given-names>
</name>
<name>
<surname>La Vecchia</surname> <given-names>C</given-names>
</name>
<name>
<surname>Bamia</surname> <given-names>C</given-names>
</name>
<name>
<surname>Benetou</surname> <given-names>V</given-names>
</name>
</person-group>. <article-title>Physical activity in breast cancer survivors: a systematic review and meta-analysis on overall and breast cancer survival</article-title>. <source>Breast</source>. (<year>2019</year>) <volume>44</volume>:<page-range>144&#x2013;52</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.breast.2019.02.001</pub-id>
</citation>
</ref>
<ref id="B39">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schmidt</surname> <given-names>ME</given-names>
</name>
<name>
<surname>Chang-Claude</surname> <given-names>J</given-names>
</name>
<name>
<surname>Vrieling</surname> <given-names>A</given-names>
</name>
<name>
<surname>Seibold</surname> <given-names>P</given-names>
</name>
<name>
<surname>Heinz</surname> <given-names>J</given-names>
</name>
<name>
<surname>Obi</surname> <given-names>N</given-names>
</name>
<etal/>
</person-group>. <article-title>Association of pre-diagnosis physical activity with recurrence and mortality among women with breast cancer</article-title>. <source>Int J Cancer</source>. (<year>2013</year>) <volume>133</volume>:<page-range>1431&#x2013;40</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/ijc.v133.6</pub-id>
</citation>
</ref>
<ref id="B40">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shachar</surname> <given-names>SS</given-names>
</name>
<name>
<surname>Heiling</surname> <given-names>H</given-names>
</name>
<name>
<surname>Muss</surname> <given-names>HB</given-names>
</name>
<name>
<surname>Meghan</surname> <given-names>D</given-names>
</name>
<name>
<surname>Wagoner</surname> <given-names>CW</given-names>
</name>
<name>
<surname>Deal</surname> <given-names>AM</given-names>
</name>
<etal/>
</person-group>. <article-title>Physical activity intervention in patients with metastatic breast cancer during active treatment: quality of life and function</article-title>. <source>Oncologist</source>. (<year>2022</year>) <volume>28</volume>:<fpage>84</fpage>&#x2013;<lpage>e70</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/oncolo/oyac232</pub-id>
</citation>
</ref>
<ref id="B41">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jia</surname> <given-names>T</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Fan</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>E</given-names>
</name>
</person-group>. <article-title>Association of healthy diet and physical activity with breast cancer: lifestyle interventions and oncology education</article-title>. <source>Front Public Health</source>. (<year>2022</year>) <volume>10</volume>:<elocation-id>797794</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fpubh.2022.797794</pub-id>
</citation>
</ref>
<ref id="B42">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lahart</surname> <given-names>IM</given-names>
</name>
<name>
<surname>Metsios</surname> <given-names>GS</given-names>
</name>
<name>
<surname>Nevill</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Carmichael</surname> <given-names>AR</given-names>
</name>
</person-group>. <article-title>Physical activity, risk of death and recurrence in breast cancer survivors: a systematic review and meta-analysis of epidemiological studies</article-title>. <source>Acta Oncol</source>. (<year>2015</year>) <volume>54</volume>:<page-range>635&#x2013;54</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3109/0284186X.2014.998275</pub-id>
</citation>
</ref>
<ref id="B43">
<label>43</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hasnaoui</surname> <given-names>S</given-names>
</name>
<name>
<surname>Van Hoye</surname> <given-names>A</given-names>
</name>
<name>
<surname>Soudant</surname> <given-names>M</given-names>
</name>
<name>
<surname>Rotonda</surname> <given-names>C</given-names>
</name>
<name>
<surname>Carvalho de Freitas</surname> <given-names>A</given-names>
</name>
<name>
<surname>Peiffert</surname> <given-names>D</given-names>
</name>
<etal/>
</person-group>. <article-title>Evaluating the feasibility and acceptability of an adapted fencing intervention in breast cancer surgery post-operative care: the RIPOSTE pilot randomized trial</article-title>. <source>Front Oncol</source>. (<year>2024</year>) <volume>14</volume>:<elocation-id>1335442</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fonc.2024.1335442</pub-id>
</citation>
</ref>
<ref id="B44">
<label>44</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Woltmann</surname> <given-names>ML</given-names>
</name>
<name>
<surname>Foster</surname> <given-names>C</given-names>
</name>
<name>
<surname>Porcari</surname> <given-names>JP</given-names>
</name>
<name>
<surname>Camic</surname> <given-names>CL</given-names>
</name>
<name>
<surname>Dodge</surname> <given-names>C</given-names>
</name>
<name>
<surname>Haible</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Evidence that the talk test can be used to regulate exercise intensity</article-title>. <source>J Strength Cond Res</source>. (<year>2015</year>) <volume>29</volume>:<page-range>1248&#x2013;54</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1519/JSC.0000000000000811</pub-id>
</citation>
</ref>
<ref id="B45">
<label>45</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hagstr&#xf6;mer</surname> <given-names>M</given-names>
</name>
<name>
<surname>Oja</surname> <given-names>P</given-names>
</name>
<name>
<surname>Sj&#xf6;str&#xf6;m</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>The International Physical Activity Questionnaire (IPAQ): a study of concurrent and construct validity</article-title>. <source>Public Health Nutr</source>. (<year>2006</year>) <volume>9</volume>:<page-range>755&#x2013;62</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1079/PHN2005898</pub-id>
</citation>
</ref>
<ref id="B46">
<label>46</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lear</surname> <given-names>SA</given-names>
</name>
<name>
<surname>Brozic</surname> <given-names>A</given-names>
</name>
<name>
<surname>Myers</surname> <given-names>JN</given-names>
</name>
<name>
<surname>Ignaszewski</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Exercise stress testing</article-title>. <source>Sports Med</source>. (<year>1999</year>) <volume>27</volume>:<fpage>285</fpage>&#x2013;<lpage>312</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.2165/00007256-199927050-00002</pub-id>
</citation>
</ref>
<ref id="B47">
<label>47</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haskell</surname> <given-names>WL</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>I-M</given-names>
</name>
<name>
<surname>Pate</surname> <given-names>RR</given-names>
</name>
<name>
<surname>Powell</surname> <given-names>KE</given-names>
</name>
<name>
<surname>Blair</surname> <given-names>SN</given-names>
</name>
<name>
<surname>Franklin</surname> <given-names>BA</given-names>
</name>
<etal/>
</person-group>. <article-title>Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association</article-title>. <source>Med Sci Sports Exerc</source>. (<year>2007</year>) <volume>39</volume>:<page-range>1423&#x2013;34</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1249/mss.0b013e3180616b27</pub-id>
</citation>
</ref>
<ref id="B48">
<label>48</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garber</surname> <given-names>CE</given-names>
</name>
<name>
<surname>Blissmer</surname> <given-names>B</given-names>
</name>
<name>
<surname>Deschenes</surname> <given-names>MR</given-names>
</name>
<name>
<surname>Franklin</surname> <given-names>BA</given-names>
</name>
<name>
<surname>Lamonte</surname> <given-names>MJ</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>I-M</given-names>
</name>
<etal/>
</person-group>. <article-title>American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise</article-title>. <source>Med Sci Sports Exerc</source>. (<year>2011</year>) <volume>43</volume>:<page-range>1334&#x2013;59</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1249/MSS.0b013e318213fefb</pub-id>
</citation>
</ref>
<ref id="B49">
<label>49</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mart&#xed;nez-Gonz&#xe1;lez</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Garc&#xed;a-Arellano</surname> <given-names>A</given-names>
</name>
<name>
<surname>Toledo</surname> <given-names>E</given-names>
</name>
<name>
<surname>Salas-Salvad&#xf3;</surname> <given-names>J</given-names>
</name>
<name>
<surname>Buil-Cosiales</surname> <given-names>P</given-names>
</name>
<name>
<surname>Corella</surname> <given-names>D</given-names>
</name>
<etal/>
</person-group>. <article-title>A 14-item mediterranean diet assessment tool and obesity indexes among high-risk subjects: the PREDIMED trial</article-title>. <source>PloS One</source>. (<year>2012</year>) <volume>7</volume>:<elocation-id>e43134</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0043134</pub-id>
</citation>
</ref>
<ref id="B50">
<label>50</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ringn&#xe9;r</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>What is principal component analysis</article-title>? <source>Nat Biotechnol</source>. (<year>2008</year>) <volume>26</volume>:<page-range>303&#x2013;4</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nbt0308-303</pub-id>
</citation>
</ref>
<ref id="B51">
<label>51</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Algeo</surname> <given-names>N</given-names>
</name>
<name>
<surname>Bennett</surname> <given-names>K</given-names>
</name>
<name>
<surname>Connolly</surname> <given-names>D</given-names>
</name>
</person-group>. <article-title>Rehabilitation interventions to support return to work for women with breast cancer: a systematic review and meta-analysis</article-title>. <source>BMC Cancer</source>. (<year>2021</year>) <volume>21</volume>:<fpage>895</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12885-021-08613-x</pub-id>
</citation>
</ref>
<ref id="B52">
<label>52</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sheppard</surname> <given-names>DM</given-names>
</name>
<name>
<surname>O&#x2019;Connor</surname> <given-names>M</given-names>
</name>
<name>
<surname>Jefford</surname> <given-names>M</given-names>
</name>
<name>
<surname>Lamb</surname> <given-names>G</given-names>
</name>
<name>
<surname>Frost</surname> <given-names>D</given-names>
</name>
<name>
<surname>Ellis</surname> <given-names>N</given-names>
</name>
<etal/>
</person-group>. <article-title>Beyond cancer&#x201d; Rehabilitation program to support breast cancer survivors to return to health, wellness and work: feasibility study outcomes</article-title>. <source>Curr Oncol</source>. (<year>2023</year>) <volume>30</volume>:<page-range>2249&#x2013;70</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/curroncol30020174</pub-id>
</citation>
</ref>
<ref id="B53">
<label>53</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abdelbasset</surname> <given-names>WK</given-names>
</name>
<name>
<surname>Ibrahim</surname> <given-names>AA</given-names>
</name>
<name>
<surname>Alsubaie</surname> <given-names>SF</given-names>
</name>
<name>
<surname>Alrawaili</surname> <given-names>SM</given-names>
</name>
<name>
<surname>Althomali</surname> <given-names>OW</given-names>
</name>
<name>
<surname>Hussein</surname> <given-names>HM</given-names>
</name>
<etal/>
</person-group>. <article-title>Awareness and knowledge of breast cancer rehabilitation among Saudi Arabia physical therapists</article-title>. <source>Eur Rev Med Pharmacol Sci</source>. (<year>2023</year>) <volume>27</volume>:<page-range>5370&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.26355/eurrev_202306_32771</pub-id>
</citation>
</ref>
<ref id="B54">
<label>54</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berretta</surname> <given-names>M</given-names>
</name>
<name>
<surname>Montopoli</surname> <given-names>M</given-names>
</name>
<name>
<surname>Cazzavillan</surname> <given-names>S</given-names>
</name>
<name>
<surname>Ceppa</surname> <given-names>F</given-names>
</name>
<name>
<surname>Santag&#xe0;</surname> <given-names>D</given-names>
</name>
<name>
<surname>Berti</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Integrative multidisciplinary approaches by the Integrative Medicine Research Group (IMRG): a new frontier in cancer setting</article-title>. <source>Eur Rev Med Pharmacol Sci</source>. (<year>2023</year>) <volume>27</volume>:<page-range>10507&#x2013;21</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.26355/eurrev_202311_34327</pub-id>
</citation>
</ref>
<ref id="B55">
<label>55</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berretta</surname> <given-names>M</given-names>
</name>
<name>
<surname>Morra</surname> <given-names>A</given-names>
</name>
<name>
<surname>Taibi</surname> <given-names>R</given-names>
</name>
<name>
<surname>Monari</surname> <given-names>F</given-names>
</name>
<name>
<surname>Maurea</surname> <given-names>N</given-names>
</name>
<name>
<surname>Ippolito</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Improved survival and quality of life through an integrative, multidisciplinary oncological approach: pathophysiological analysis of four clinical cancer cases and review of the literature</article-title>. <source>Front Pharmacol</source>. (<year>2022</year>) <volume>13</volume>:<elocation-id>867907</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fphar.2022.867907</pub-id>
</citation>
</ref>
<ref id="B56">
<label>56</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berretta</surname> <given-names>M</given-names>
</name>
<name>
<surname>Rinaldi</surname> <given-names>L</given-names>
</name>
<name>
<surname>Taibi</surname> <given-names>R</given-names>
</name>
<name>
<surname>Tralongo</surname> <given-names>P</given-names>
</name>
<name>
<surname>Fulvi</surname> <given-names>A</given-names>
</name>
<name>
<surname>Montesarchio</surname> <given-names>V</given-names>
</name>
<etal/>
</person-group>. <article-title>Physician attitudes and perceptions of complementary and alternative medicine (CAM): a multicentre Italian study</article-title>. <source>Front Oncol</source>. (<year>2020</year>) <volume>10</volume>:<elocation-id>594</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fonc.2020.00594</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>